Home Cart 0 Sign in  
X

[ CAS No. 15862-37-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 15862-37-0
Chemical Structure| 15862-37-0
Chemical Structure| 15862-37-0
Structure of 15862-37-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 15862-37-0 ]

Related Doc. of [ 15862-37-0 ]

Alternatived Products of [ 15862-37-0 ]

Product Details of [ 15862-37-0 ]

CAS No. :15862-37-0 MDL No. :MFCD09266223
Formula : C5H2Br2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :OQKWPJCAKRVADO-UHFFFAOYSA-N
M.W : 281.89 Pubchem ID :298470
Synonyms :

Calculated chemistry of [ 15862-37-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.46
TPSA : 58.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.32 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.55
Log Po/w (XLOGP3) : 2.4
Log Po/w (WLOGP) : 2.51
Log Po/w (MLOGP) : 0.82
Log Po/w (SILICOS-IT) : 0.66
Consensus Log Po/w : 1.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.44
Solubility : 0.103 mg/ml ; 0.000365 mol/l
Class : Soluble
Log S (Ali) : -3.27
Solubility : 0.15 mg/ml ; 0.000531 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.11
Solubility : 0.221 mg/ml ; 0.000783 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.31

Safety of [ 15862-37-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H317-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 15862-37-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 15862-37-0 ]
  • Downstream synthetic route of [ 15862-37-0 ]

[ 15862-37-0 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 15862-37-0 ]
  • [ 97966-00-2 ]
Reference: [1] Journal of the Chemical Society, 1952, p. 2042,2044
[2] Journal of the Chemical Society, 1952, p. 2042,2044
  • 2
  • [ 15862-37-0 ]
  • [ 588729-99-1 ]
Reference: [1] Journal of the Chemical Society, 1952, p. 2042,2044
[2] Journal of the Chemical Society, 1952, p. 2042,2044
  • 3
  • [ 15862-37-0 ]
  • [ 90902-84-4 ]
YieldReaction ConditionsOperation in experiment
76% at 80℃; for 15 h; (b) 2,5-Dibromo-3-aminopyridine; 2,5-Dibromo-3-nitropyridine (2.5 g, 8.87 mmol) was stirred in acetic acid (10 mL). Powdered iron (2.476 g, 44.3 mmol) was added and the solution heated at 800C for 15 minutes with vigorous stirring. The reaction mixture was filtered through Celite washed with ether and EtOAc. The resulting organic layer was washed with water and brine, dried over magnesium sulfate and filtered. The solvent was removed to give the crude product. Crude product was purified on silica eluting with 0-30percent EtOAc :hexane to give the title compound (1.7 g, 6.75 mmol, 76 percent yield) as white solid. MS (ES+) m/z 252(MH+).
67.39% at 80℃; for 2 h; To the solution of 2,5-Dibromo-3-nitro-pyridine (10.30 g, 35.47 mmol) in the 100 ml of ethanol was added SnCI2 (24.0 g, 106.42 mmol) slowly. The reaction mixture was heated at 800C for 2 h. After the completion of the reaction mixture (TLC monitoring), the reaction mixture was evaporated to dryness under reduced pressure. Water (250 ml_) was added, white solid separated out, then, basified the reaction mixture with NaOH Solution. To this added the 250 ml of ethyl acetate. Filtered it and washed the residue with ethyl acetate, layers are separated, dried (Na2SO4), filtered, concentrated to give the desired product (6.2Og, 67.39percent).
Reference: [1] Bulletin des Societes Chimiques Belges, 1988, vol. 97, # 1, p. 51 - 54
[2] Patent: WO2008/128961, 2008, A1, . Location in patent: Page/Page column 37; 73
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3927 - 3936
[4] Patent: WO2007/107758, 2007, A1, . Location in patent: Page/Page column 125
[5] Journal of the Chemical Society, 1952, p. 2042,2044
[6] Patent: US2010/331293, 2010, A1, . Location in patent: Page/Page column 70
[7] Patent: WO2015/95795, 2015, A1, . Location in patent: Paragraph 0628
  • 4
  • [ 15862-37-0 ]
  • [ 7440-44-0 ]
  • [ 90902-84-4 ]
Reference: [1] Patent: US5445763, 1995, A,
  • 5
  • [ 15862-37-0 ]
  • [ 573675-27-1 ]
Reference: [1] Journal of the Chemical Society, 1952, p. 2042,2044
  • 6
  • [ 15862-37-0 ]
  • [ 669066-89-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 7
  • [ 15862-34-7 ]
  • [ 15862-37-0 ]
YieldReaction ConditionsOperation in experiment
97% With phosphorus(V) oxybromide In N,N-dimethyl-formamide; toluene at 90℃; for 16 h; Intermediate 12; N-[(R)-1-(5-Bromo-3-fluoro-pyridin-2-yl)-ethyl]-acetamide Step A: 2,5-Dibromo-3-nitro-pyridine To a suspension 5-bromo-3-nitro-pyridin-2-ol (20 g, 91.32 mmol) in toluene (100 ml) was added DMF (0.7 ml, 9.13 mmol) and the mixture was heated to 90° C. (the reaction mixture was protected from light). A solution of POBr3 (31.41 g, 109.51 mmol) in toluene (40 ml) was added dropwise at 90° C. and the reaction mixture was stirred at that temperature for 16 h. The mixture was allowed to cool to room temperature and toluene (50 ml) and water (50 ml) were added. The organic layer was separated, washed successively with aqueous 1N NaOH (60 ml), water (60 ml) and brine (30 ml), dried with Na2SO4 and evaporated obtain the title compound as yellow solid (25.2 g, 97percent).
97%
Stage #1: With phosphorus(V) oxybromide In N,N-dimethyl-formamide; toluene at 90℃; for 16 h; Darkness
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide; toluene
Step A: 2,5-Dibromo-3-nitro-pyridineTo a suspension 5-bromo-3-nitro-pyridin-2-ol (20 g, 91.32 mmol) in toluene (100 ml) was added DMF (0.7 ml, 9.13 mmol) and the mixture was heated to 90°C (the reaction mixture was protected from light). A solution of POBr3 (31.41 g,109.51 mmol) in toluene (40 ml) was added dropwise at 90°C and the reaction mixture was stirred at that temperature for 16 h. The mixture was allowed to cool to room temperature and toluene (50 ml) and water (50 ml) were added. The organic layer was separated, washed successively with aqueous IN NaOH (60 ml), water (60 ml) and brine (30 ml), dried with Na2S04 and evaporated obtain the title compound as yellow solid (25.2 g, 97percent).
80.03% With phosphorus tribromide In N,N-dimethyl-formamide at 120℃; for 0.333333 h; To a solution of 5-Bromo-3-nitro-pyridin-2-ol (10.0 g, 45.66 mmol) in 70 ml of toluene and 7 ml of DMF was added PBr3 (6.60 ml, 68.49 mmol) and the reaction mixture was heated at 12O0C for 20 min under nitrogen atmosphere. After the completion of the reaction mixture (TLC monitoring), water (100 mL) was added and extracted with ethyl acetate (3 x 200 mL). The combined organics was washed with water, brine, dried (Na2SO4), filtered and concentrated to get the desired product (10.30 g, 80.03percent).
Reference: [1] Patent: US2012/165338, 2012, A1, . Location in patent: Page/Page column 2
[2] Patent: WO2012/89601, 2012, A1, . Location in patent: Page/Page column 53
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3927 - 3936
[4] Patent: WO2007/107758, 2007, A1, . Location in patent: Page/Page column 124
[5] Journal of the Chemical Society, 1952, p. 2042,2044
[6] Journal of the American Chemical Society, 1955, vol. 77, p. 6053
[7] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
[8] Patent: WO2005/63690, 2005, A1, . Location in patent: Page/Page column 28
[9] Journal of Organic Chemistry, 2009, vol. 74, # 12, p. 4547 - 4553
[10] Patent: WO2006/52514, 2006, A1, . Location in patent: Page/Page column 7
[11] Patent: WO2006/132837, 2006, A1, . Location in patent: Page/Page column 19
  • 8
  • [ 6945-68-2 ]
  • [ 15862-37-0 ]
YieldReaction ConditionsOperation in experiment
58.9%
Stage #1: With hydrogen bromide In water at 0 - 5℃;
Stage #2: at 0℃; for 0.75 h;
Stage #3: With sodium hydroxide In water at 20℃; for 1 h;
(1) Production of 2,5-dibromo-3-nitropyridine: Hydrogen bromide (48 percent in H2O, 13 mL) was stirred at 0°C, to which 5-bromo-3-nitropyridin-2-amine (5.0 g, 22.9 mmol) was dropwise added with its inner temperature kept at 5°C or lower. After the addition, bromine (4.69 mL) and sodium sulfite (6.32 g) were added to it in that order. After stirred at 0°C for 45 minutes, aqueous sodium hydroxide (9.16 g) solution (10 mL) was added thereto and stirred at room temperature for 1 hour. The resulting solid was taken out through filtration, washed with water and dried to obtain the intended compound (3.80 g, 58.9 percent).
35%
Stage #1: With hydrogen bromide; bromine In water at 0℃;
Stage #2: With sodium nitrite In water at 0℃;
Stage #3: With sodium hydroxide In waterCooling with ice
Synthesis Example 2; Synthesis of N-ethyl-N-methyl-N'[2,5-dimethyl-6-(4-t-butylphenyl)pyridin-3- y 1] formamidine (Compound No .11); (1); Bromine (68.81 mmol, 3.5 ml) was gradually added dropwise to an aqueous solution of 48percent hydrobromic acid (120 ml) of 2-amino-5-bromo-3-nitropyridine (22.93 mmol, 5.0 g) at 0°C, followed by stirring at the same temperature for 1 hour. An aqueous solution prepared by dissolving sodium nitrite (57.34 mmol, 4.0 g) in 60 ml of water was gradually added dropwise, followed by stirring at the same temperature for1.5 hours. To the resulting reaction mixture, 10 mol/liter sodium hydroxide aqueous solution was added on ice to neutralize, and an aqueous layer was extracted with ethyl acetate. An organic layer was washed with saturated saline, dried over anhydrous sodium sulfate, and filtered, followed by distilling away a solvent under reduced pressure. The resulting crude product was purified with column chromatography to obtain 2.24 g of 2,5-dibromo-3-nitropyridine (yield 35percent). 1H NMR δ ppm (300 MHz, CDCl3) data of this compound are 8.66 (d, 2H, J=2.4Hz), 8.27 (d, 2H, J=2.1Hz).
Reference: [1] Patent: EP1757594, 2007, A1, . Location in patent: Page/Page column 76
[2] Patent: WO2009/88103, 2009, A1, . Location in patent: Page/Page column 16
[3] Tetrahedron, 2003, vol. 59, # 43, p. 8555 - 8570
[4] Journal of the Chemical Society, 1952, p. 2042,2044
[5] Patent: US2009/69319, 2009, A1, . Location in patent: Page/Page column 31
  • 9
  • [ 15862-34-7 ]
  • [ 15862-37-0 ]
YieldReaction ConditionsOperation in experiment
100% With pyridine; phosphorus(V) oxybromide In toluene at 90℃; for 15.5 h; Example 15; 4-{7- [(2,3-dihydro [1 ,4] dioxino [2,3-c] pyridin-7-ylmethyl)amino] -5- methyl-6-oxo-5,6,7,8-tetrahydro-l,5-naphthyridin-3-yl}-6-(methyloxy)pyrido[2,3- b]pyrazin-3(4H)-one; <n="74"/>(a) 2,5-Dibromo-3-nitropyridine; 5-Bromo-3-nitro-2(lH)-pyridinone (5g, 22.83 mmol) was suspended in toluene (50 ml). DMF (0.177 ml, 2.283 mmol) was added and the mixture was protected from light. A solution of phoshorous oxybromide (7.85 g, 27.4 mmol) in toluene (50 ml) was added to the pyridine mixture over 1.5h at 90 0C. The reaction mixture was heated at 90 0C for 14h, cooled down and extracted with water. The organic layer was washed with IN NaOH and brine and dried over MgSOφ The solvent was removed to give title compound (6.45 g, 22.88 mmol, 100 percent yield) as yellow solid. MS (ES+) m/z 282(MH+).
Reference: [1] Patent: WO2008/128961, 2008, A1, . Location in patent: Page/Page column 72-73
  • 10
  • [ 15862-34-7 ]
  • [ 7789-59-5 ]
  • [ 15862-37-0 ]
Reference: [1] Patent: US5445763, 1995, A,
  • 11
  • [ 6332-56-5 ]
  • [ 15862-37-0 ]
Reference: [1] Journal of the American Chemical Society, 1955, vol. 77, p. 6053
  • 12
  • [ 1072-97-5 ]
  • [ 15862-37-0 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 43, p. 8555 - 8570
  • 13
  • [ 15862-37-0 ]
  • [ 573675-25-9 ]
YieldReaction ConditionsOperation in experiment
68% at 90℃; for 17 h; Step B: 5-Bromo-3-nitro-pyridine-2-carbonitrile To a stirred solution of 2,5-dibromo-3-nitro-pyridine (25 g, 88.68 mmol) in propionitrile (100 ml) was added CuCN (8.7 g, 97.55 mmol) and the mixture was heated to 90° C. for 17 h. Then it was allowed to cool to room temperature, diluted with EtOAc, washed twice with brine, dried with Na2SO4 and concentrated. The remaining residue was purified by chromatography (silica gel; DCM/MeOH 95:5-85:15) to obtain the title compound as yellow solid (17.5 g, 68percent).
68% at 90℃; for 17 h; Step B: 5-Bromo-3-nitro-pyridine-2-carbonitrile OTo a stirred solution of 2,5-dibromo-3-nitro-pyridine (25 g, 88.68 mmol) in propionitrile (100 ml) was added CuCN (8.7 g, 97.55 mmol) and the mixture was heated to 90°C for 17 h. Then it was allowed to cool to room temperature, diluted with EtOAc, washed twice with brine, dried with Na2S04 and concentrated. The remaining residue was purified by chromatography (silica gel; DCM / MeOH 95:5-85: 15) to obtain the title compound as yellow solid (17.5 g, 68percent).
Reference: [1] Patent: US2012/165338, 2012, A1, . Location in patent: Page/Page column 22
[2] Patent: WO2012/89601, 2012, A1, . Location in patent: Page/Page column 53-54
[3] Journal of Organic Chemistry, 2009, vol. 74, # 12, p. 4547 - 4553
  • 14
  • [ 15862-37-0 ]
  • [ 544-92-3 ]
  • [ 573675-25-9 ]
YieldReaction ConditionsOperation in experiment
59% at 150℃; for 2 h; (2) Production of 5-bromo-2-cyano-3-nitropyridine: 2,5-Dibromo-3-nitropyridine (3.80 g, 13.4 mmol) and copper cyanide (2.42 g, 26.8 mmol) were mixed, and stirred under heat at 150°C for 2 hours. After cooled to room temperature, the contents were filtered, and the residue was washed with acetone. The mother liquid was concentrated, and the resulting residue was purified through silica gel column chromatography (hexane/ethyl acetate = 9/1 to 3/1) to obtain the intended compound (1.80 g, 59 percent) as a yellow solid.
Reference: [1] Patent: EP1757594, 2007, A1, . Location in patent: Page/Page column 76
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
[3] Patent: WO2005/42498, 2005, A2, . Location in patent: Page/Page column 43; 44
[4] Patent: WO2006/52514, 2006, A1, . Location in patent: Page/Page column 7-8
[5] Patent: WO2006/132837, 2006, A1, . Location in patent: Page/Page column 19
  • 15
  • [ 15862-37-0 ]
  • [ 4367-08-2 ]
  • [ 573675-25-9 ]
Reference: [1] Patent: WO2005/63690, 2005, A1, . Location in patent: Page/Page column 29
  • 16
  • [ 15862-37-0 ]
  • [ 89415-54-3 ]
Reference: [1] Patent: WO2018/67786, 2018, A1,
  • 17
  • [ 15862-37-0 ]
  • [ 669066-91-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 18
  • [ 15862-37-0 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 19
  • [ 15862-37-0 ]
  • [ 886373-28-0 ]
Reference: [1] Patent: US2012/165338, 2012, A1,
[2] Patent: WO2012/89601, 2012, A1,
[3] Patent: WO2006/132837, 2006, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 15862-37-0 ]

Bromides

Chemical Structure| 84487-14-9

[ 84487-14-9 ]

2-Bromo-3-nitropyridine-4-amine

Similarity: 0.82

Chemical Structure| 23056-45-3

[ 23056-45-3 ]

2-Bromo-4-methyl-3-nitropyridine

Similarity: 0.82

Chemical Structure| 23056-46-4

[ 23056-46-4 ]

2-Bromo-5-methyl-3-nitropyridine

Similarity: 0.81

Chemical Structure| 55304-80-8

[ 55304-80-8 ]

2,6-Dibromo-3-nitropyridine

Similarity: 0.80

Chemical Structure| 75806-86-9

[ 75806-86-9 ]

2-Bromo-5-chloro-3-nitropyridine

Similarity: 0.79

Nitroes

Chemical Structure| 84487-14-9

[ 84487-14-9 ]

2-Bromo-3-nitropyridine-4-amine

Similarity: 0.82

Chemical Structure| 23056-45-3

[ 23056-45-3 ]

2-Bromo-4-methyl-3-nitropyridine

Similarity: 0.82

Chemical Structure| 23056-46-4

[ 23056-46-4 ]

2-Bromo-5-methyl-3-nitropyridine

Similarity: 0.81

Chemical Structure| 55304-80-8

[ 55304-80-8 ]

2,6-Dibromo-3-nitropyridine

Similarity: 0.80

Chemical Structure| 75806-86-9

[ 75806-86-9 ]

2-Bromo-5-chloro-3-nitropyridine

Similarity: 0.79

Related Parent Nucleus of
[ 15862-37-0 ]

Pyridines

Chemical Structure| 84487-14-9

[ 84487-14-9 ]

2-Bromo-3-nitropyridine-4-amine

Similarity: 0.82

Chemical Structure| 23056-45-3

[ 23056-45-3 ]

2-Bromo-4-methyl-3-nitropyridine

Similarity: 0.82

Chemical Structure| 23056-46-4

[ 23056-46-4 ]

2-Bromo-5-methyl-3-nitropyridine

Similarity: 0.81

Chemical Structure| 55304-80-8

[ 55304-80-8 ]

2,6-Dibromo-3-nitropyridine

Similarity: 0.80

Chemical Structure| 75806-86-9

[ 75806-86-9 ]

2-Bromo-5-chloro-3-nitropyridine

Similarity: 0.79